Capital Royalty backs Valeritas with $100m

The healthcare-focused debt fund manager has provider a term loan to insulin device manufacturer Valeritas.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.